This webinar will cover biosimilar patent challenges at the PTAB. We will explore topics including:
- The type of biologics patents being challenged at the PTAB and the success rate for each type
- Timing of challenges relative to aBLA filing/litigation
- Number of challenges for given patent/given drug
- Implications of results of these PTAB challenges for biologics manufacturers
- Strategies for biosimilars companies in light of PTAB stats
Visit this page to register.